Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14521230 | 1.00 | ALDH1A1 (0.41) | ALDH1A1DPP4POLBSMN1; SMN2GRIN2D | |
| Acrylamide SCHEMBL7521468 | 0.94 | ALDH1A1 (0.39) | ALDH1A1DPP4POLB | |
| SCHEMBL16191438 | 0.94 | ALDH1A1 (0.37) | ALDH1A1DPP4POLBSMN1; SMN2 | |
| SCHEMBL6919191 | 0.89 | ALDH1A1 (0.48) | ALDH1A1DPP4POLBSMN1; SMN2 | |
| SCHEMBL2446348 | 0.89 | ALDH1A1 (0.48) | ALDH1A1DPP4POLBSMN1; SMN2 | |
| SCHEMBL12610741 | 0.89 | ALDH1A1 (0.38) | ALDH1A1DPP4POLBSMN1; SMN2 | |
| SCHEMBL2446346 | 0.82 | ALDH1A1 (0.42) | ALDH1A1DPP4POLBSMN1; SMN2 | |
| SCHEMBL8152936 | 0.81 | TSHR (0.34) | DPP4 | |
| SCHEMBL8741900 | 0.78 | — | — | |
| SCHEMBL4342168 | 0.77 | ALDH1A1 (0.38) | ALDH1A1DPP4POLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2026-01-27 | — | — | US | claimed |
| CN-119874247-A | Early strength agent for sprayed concrete and preparation method thereof | 山东中岩建材科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12247156-B2 | Re-crosslinkable particle for conformance control and temporary plugging | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2025-03-11 | — | — | US | claimed |
| CN-115819800-B | Double-network hydrogel based on pre-embedded inorganic micro-nano particles, and preparation method and application thereof | 山东大学 | 2024-12-27 | — | — | CN | claimed |
| US-20240132771-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2024-04-25 | — | — | US | claimed |
| EP-2968165-B1 | COMPOSITIONS AND ASSOCIATED METHODS FOR RADIOISOTOPE-BINDING MICROPARTICLES | BIOSPHERE MEDICAL INC (US) | 2023-09-13 | — | — | EP | claimed |
| EP-4240804-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | The Curators Of The University Of Missouri (US) | 2023-09-13 | — | — | EP | claimed |
| CN-116024307-B | Single cell library construction method containing tissue position information and sequencing method | 北京寻因生物科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-116024307-A | Single cell library construction method containing tissue position information and sequencing method | 北京寻因生物科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| US-20230055352-A1 | RE-CROSSLINKABLE PARTICLE FOR CONFORMANCE CONTROL AND TEMPORARY PLUGGING | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2023-02-23 | — | — | US | claimed |
| EP-0474617-A1 | Process for surface modifying a support membrane | MONSANTO COMPANY (US) | 1992-03-11 | — | — | EP | claimed |
| EP-0159694-B1 | RADIATION PROCESS FOR PREPARATION OF ELECTROPHORESIS GEL MATERIAL | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-15 | — | — | EP | claimed |
| EP-0225403-B1 | REHYDRATABLE POLYACRYLAMIDE GELS | BECKMAN INSTRUMENTS, INC. (US) | 1991-07-24 | — | — | EP | claimed |
| EP-0336535-A1 | Gas separation by composite solvent-swollen membranes | BEND RESEARCH, INC. (US) | 1989-10-11 | — | — | EP | claimed |
| EP-0324539-A2 | Improved capillary gel electrophoresis columns | NORTHEASTERN UNIVERSITY (US) | 1989-07-19 | — | — | EP | claimed |
| US-4824443-A | HIGHLY POLAR SOLVENT | BEND RESEARCH, INC. (US) | 1989-04-25 | — | — | US | claimed |
| EP-0141001-B1 | IMMUNOLOGICAL DETERMINATION OF APOLIPOPROTEIN B FROM LOW DENSITY LIPOPROTEINS IN SERUM | SPIRAL Société à responsabilité limitée dite : (FR) | 1988-12-28 | — | — | EP | claimed |
| EP-0273724-A2 | Acid gas scrubbing by composite solvent-swollen membranes | BEND RESEARCH, INC. (US) | 1988-07-06 | — | — | EP | claimed |
| US-4737166-A | SEPARATION OF HYDROGEN SULFIDE AND CARBON DIOXIDE FROM HYDROGEN, CARBON MONOXIDE AND HYDROCARBON GASES; SUPPORTED POLYMER | BEND RESEARCH, INC. (US) | 1988-04-12 | — | — | US | claimed |
| EP-0141001-A1 | Immunological determination of apolipoprotein B from low density lipoproteins in serum | SPIRAL Société à responsabilité limitée dite : (FR) | 1985-05-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | PHOSPHO1, TERT, AS3MT | ALDH1A1 2931/4885DPP4 4625/4885POLB 1267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.